Literature DB >> 10856896

Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity.

M Di Fulvio1, A H Coleoni, C G Pellizas, A M Masini-Repiso.   

Abstract

The effects of the tri-iodothyronine (T(3)) secreted by thyroid cells on the growth of the thyrocyte are poorly known. In this study we analyzed the effects of T(3) on the proliferation of bovine thyroid follicles in primary culture previously depleted of endogenous T(3). Cellular deoxiribonucleic acid (DNA) synthesis, determined by [(3)H]thymidine incorporation, was stimulated by T(3) (0.1-5.0 nM) for 24 h in a concentration-dependent fashion with a maximal effect at 1.0 nM T(3) (P<0.01). This T(3) action was time-dependent when assayed from 12 to 72 h. The induction of mitogenic activity was corroborated by the increase in proliferating cell nuclear antigen (PCNA) measured by Western blot analysis. PCNA increased after treatment with T(3) (0.1-5.0 nM) in a concentration-dependent manner. Since T(3) modifies the activity of growth factors whose actions are mainly mediated by tyrosine kinase (TK) activation in diverse cellular types, we assayed the effects of genistein, a general TK inhibitor, and tyrphostin A25, a specific epidermal growth factor (EGF)-receptor (EGFR)-dependent TK activity inhibitor, on the proliferative effects of T(3). The T(3)-induced [(3)H]thymidine incorporation was inhibited by both agents in a concentration-dependent manner. A significant increase in the total TK activity measured in cellular protein extracts was induced by 0.5 and 1.0 nM T(3) (P<0.001). Tyrosine phosphorylation of the EGFR was also stimulated by T(3) (P<0.001) with no change in the EGFR expression as determined by Western blot analysis. Both, the T(3)-stimulated [(3)H]thymidine incorporation and the TK activity were inhibited by a anti-mouse EGF antibody. These results lead us to propose that T(3) could operate as a proliferative agent in bovine thyroid cells through a mechanism involving an autocrine/paracrine EGF/EGFR-dependent regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856896     DOI: 10.1677/joe.0.1660173

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Cell cycle-dependent expression of thyroid hormone receptor-beta is a mechanism for variable hormone sensitivity.

Authors:  Padma Maruvada; Natalia I Dmitrieva; Joyce East-Palmer; Paul M Yen
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

2.  The elucidation of novel SH2 binding sites on PLD2.

Authors:  M Di Fulvio; N Lehman; X Lin; I Lopez; J Gomez-Cambronero
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

3.  Human rs75776403 polymorphism links differential phenotypic and clinical outcomes to a CLEC18A p.T151M-driven multiomics.

Authors:  Yu-Wen Hsu; Henry Sung-Ching Wong; Wan-Chen Huang; Yi-Hung Yeh; Chwan-Deng Hsiao; Wei-Chiao Chang; Shie-Liang Hsieh
Journal:  J Biomed Sci       Date:  2022-06-18       Impact factor: 12.771

4.  Localization and expression of thyroid hormone receptors normal and neoplastic human thyroid.

Authors:  A Crescenzi; M F Graziano; E Carosa; E Papini; N Rucci; F Nardi; P Trimboli; A Calvanese; E A Jannini; M D'Armiento
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 5.  Thyroid hormones and growth in health and disease.

Authors:  Ömer Tarım
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-06-08

6.  Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.

Authors:  Ran Meng; Heng-Yuan Tang; Jennifer Westfall; David London; James H Cao; Shaker A Mousa; Mary Luidens; Aleck Hercbergs; Faith B Davis; Paul J Davis; Hung-Yun Lin
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.